Skip to content

Shattuck Labs, Inc. STTK Free cash flow margin

Free cash flow margin at other companies

Eli Lilly logo
Eli LillyLLY
16.4%+8.7pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
18.5%-4.3pp
Amgen logo
AmgenAMGN
23.1%-8.9pp
AbbVie logo
AbbVieABBV
31.8%+5.0pp
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-624.9%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-11,123.8%-13,374pp

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Calculated from Shattuck Labs, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s free cash flow margin?
Shattuck Labs, Inc. (STTK) reported free cash flow margin of -4,140.8% in Q1 2026.
How has Shattuck Labs, Inc.'s free cash flow margin changed year-over-year?
Shattuck Labs, Inc.'s free cash flow margin decreased by 237.9% year-over-year, from -1,225.5% to -4,140.8%.
What is the long-term trend for Shattuck Labs, Inc.'s free cash flow margin?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s free cash flow margin has grown at a 61.4% compound annual growth rate (CAGR), from -364.9% to -3,995.3%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.